EUVIMEDEUVIMED entdecken
Crossref

Gastrodin ameliorates diabetic nephropathy by activating the AMPK/Nrf2 pathway

Shuqin Zhao, Qingyun Pan, Xiaolin Lin, Xian Li, Li Qu

Journal of Molecular Histology · 2024

DOI: 10.1007/s10735-024-10273-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Histology, 2024. Verfasst von Shuqin Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Internal Medicine, Yantai Yuhuangding Hospital, No. 20 Yuhuangding East Road, Zhifu District, Yantai, Shandong, 264099, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Glucosides, NF-E2-Related Factor 2, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN) is a leading cause of end-stage kidney failure, contributing to elevated morbidity and mortality rates in individuals with diabetes. Despite its potential renoprotective effects, the molecular mechanism by which gastrodin (GSTD) impacts DN remains unclear. To investigate this, mice were initially induced with DN via intraperitoneal streptozotocin (STZ) injection (50 mg/kg) and subsequently treated with varying doses of GSTD (5, 10, 20 mg/kg). Furthermore, the potential molecular mechanism of GSTD in mitigating DN was explored in vivo in conjunction with compound C, an inhibitor of 5'-AMP-activated protein kinase (AMPK). Subsequently, the blood weight, fasting blood glucose levels, and renal injury markers of DN-afflicted mice were assessed. Additionally, renal tissues were subjected to quantitative reverse-transcriptase-polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) to evaluate inflammatory factor levels, colorimetric assays to measure renal malondialdehyde (MDA) levels, and immunoblotting analysis to examine AMPK/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. The results demonstrated that a 6-week GSTD regimen effectively improved metabolic manifestations associated with DN, including reductions in fasting blood glucose levels, 24-hour urine output, renal indices, amelioration of glomerular histopathological abnormalities, diminished glycogen accumulation, and fibrosis. Furthermore, DN-afflicted renal tissues exhibited decreased MDA levels and elevated expression of AMPK/Nrf2 pathway-associated proteins. The beneficial effects of GSTD on DN and its protein modulation were reversed upon co-intervention with compound C. Together, our findings imply that GSTD improves DN by activating the AMPK/Nrf2 pathway, thereby mitigating STZ-induced renal damage, inflammatory responses, and oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesGlucosidesNF-E2-Related Factor 2AMP-Activated Protein KinasesBenzyl AlcoholsSignal TransductionAnimalsMiceMaleDiabetes Mellitus, ExperimentalKidneyOxidative StressBlood Glucose

Stichwörter der Autor:innen

AMPK/Nrf2 pathwayDiabetic nephropathyInflammatory responseOxidative stressTensin

Substanzen

GlucosidesNF-E2-Related Factor 2AMP-Activated Protein KinasesgastrodinBenzyl AlcoholsNfe2l2 protein, mouseBlood Glucose

Autor:innen und Institutionen

  • Pediatric Internal Medicine, Yantai Yuhuangding Hospital, No. 20 Yuhuangding East Road, Zhifu District, Yantai, Shandong, 264099, China.
  • Department of Endocrinology, the Fifth Hospital in Wuhan, No. 122, Xianzheng Street, Hanyang District, Wuhan, Hubei, 430050, China.
  • Department of Endocrinology, Yantai Yuhuangding Hospital, No. 20 Yuhuangding East Road, Zhifu District, Yantai, Shandong, 264099, China.
  • Department of Emergency, Yantai Yuhuangding Hospital, No. 20 Yuhuangding East Road, Zhifu District, Yantai, Shandong, 264099, China. Quli881@163.com.

Zitieren

APA

Zhao, S., Pan, Q., Lin, X., Li, X., & Qu, L. (2024). Gastrodin ameliorates diabetic nephropathy by activating the AMPK/Nrf2 pathway. Journal of Molecular Histology. https://doi.org/10.1007/s10735-024-10273-7

Vancouver

Zhao S, Pan Q, Lin X, Li X, Qu L. Gastrodin ameliorates diabetic nephropathy by activating the AMPK/Nrf2 pathway. Journal of Molecular Histology. 2024. doi:10.1007/s10735-024-10273-7

BibTeX
@article{Zhao2024,
  author = {Zhao, Shuqin and Pan, Qingyun and Lin, Xiaolin and Li, Xian and Qu, Li},
  title = {Gastrodin ameliorates diabetic nephropathy by activating the AMPK/Nrf2 pathway},
  journal = {Journal of Molecular Histology},
  year = {2024},
  doi = {10.1007/s10735-024-10273-7}
}
Kostenlos starten →